EGFR and neoplasm: Immunohistochemical studies showed that Ki-67 (MIB-1) proliferation-related labeling index was very low at 1 % or less, and tumor cells revealed sporadic immunoreactivity for p53, but a negative staining for epidermal growth factor receptor (EGFR) (Fig. 2b–d).